Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0007921835
Wed, 06.01.2021       Vivoryon Therapeutics N.V.
DE0007921835

Vivoryon Therapeutics N.V. new ISIN code   HALLE (SAALE) / MUNICH, Germany, 06 January 2021 - in connection with the conversion into an N.V., a public company under the laws of the Netherlands (naamloze vennootschap, "N.V.") which has taken effect on 28 November 2020, Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY) announces that the shares  [ … ]
Technical analysis
To the publication
Wed, 16.12.2020       Vivoryon Therapeutics N.V.
DE0007921835

Vivoryon Therapeutics N.V. new Home Member State   HALLE (SAALE) / MUNICH, Germany, 16 December 2020 - as a consequence of the conversion into an N.V., a public company under the laws of the Netherlands (naamloze vennootschap, "N.V.") which has taken effect on 28 November 2020, Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; ISIN DE0007921835 [ … ]
Technical analysis
To the publication
Mon, 14.12.2020       Vivoryon Therapeutics AG
DE0007921835

Successful Relocation of Vivoryon Shares Package HALLE (SAALE) / MUNICH, GERMANY, 14 December 2020 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; ISIN DE0007921835) has been informed by Hauck & Aufhäuser Privatbankiers AG that the remaining stake held by MorphoSys AG, comprising of around 6.5% of the share capital, has been successful [ … ]
Technical analysis
To the publication
Mon, 30.11.2020       Vivoryon Therapeutics AG
DE0007921835

Vivoryon Therapeutics AG Announces Conversion into Vivoryon Therapeutics N.V.   HALLE (SAALE) / MUNICH, Germany, 30 November 2020 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY) announced today that it has completed its conversion into an N.V., a public company under the laws of the Netherlands (naamloze vennootschap, "N.V.") effective from [ … ]
Technical analysis
To the publication
Thu, 26.11.2020       Vivoryon Therapeutics AG
DE0007921835

Vivoryon Therapeutics Reports Third Quarter 2020 HALLE (SAALE) / MUNICH, Germany, 26 November 2020 - Vivoryon Therapeutics AG (Euronext Amsterdam: VVY; ISIN DE0007921835) announced today its third quarter business update for the period ending September 30, 2020. The third quarter 2020 report is available for download on the Company website (https: [ … ]
Technical analysis
To the publication
Thu, 19.11.2020       Vivoryon Therapeutics AG
DE0007921835

Vivoryon Therapeutics AG to Publish its Third Quarter 2020 Business Update on November 26, 2020 HALLE (SAALE) / Munich, Germany, 19 November 2020 - Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835), a biotechnology company focused on developing first-in-class therapeutics targeting post-translational modifying enzymes, announce [ … ]
Technical analysis
To the publication
Thu, 01.10.2020       Vivoryon Therapeutics AG
DE0007921835

Ordinary General Meeting of Shareholders of Vivoryon Therapeutics AG All proposed resolutions approved with large majority   HALLE (SAALE) / MUNICH, Germany, 01 October 2020 - Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835) announced today that its shareholders approved all resolutions proposed by the Company's management a [ … ]
Technical analysis
To the publication
Thu, 03.09.2020       Vivoryon Therapeutics AG
DE0007921835

Vivoryon Therapeutics Announces Notice of its Ordinary General Meeting of Shareholders to be Held on September 30, 2020   HALLE (SAALE) / MUNICH, GERMANY, 3 September 2020 - Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835) invites all shareholders to Vivoryon Therapeutics' ordinary general meeting of shareholders to be held on [ … ]
Technical analysis
To the publication
Thu, 27.08.2020       Vivoryon Therapeutics AG
DE0007921835

Vivoryon Therapeutics AG plans conversion into Naamloze Vennootschap (N.V.) under Dutch law Vivoryon Therapeutics intends the transfer of the statutory seat to Amsterdam, the Netherlands, leading to a conversion into a public company under the laws of the Netherlands The administrative seat and the business operations will remain in Germany The  [ … ]
Technical analysis
To the publication
Thu, 27.08.2020       Vivoryon Therapeutics AG
DE0007921835

Vivoryon Therapeutics Reports Financial Results for H1 2020 and Provides Corporate Update - Conference call and webcast in English at 3:00 pm CEST / 09:00 am EDT - Vivoryon and Nordic Bioscience collaboration - Meprin protease inhibitors development program   HALLE (SAALE) / MUNICH, Germany, 27 August 2020 - Vivoryon Therapeutics AG (Euronext [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Tuesday, 02.07.2024, Calendar Week 27, 184th day of the year, 182 days remaining until EoY.